Bradesco 1Q Profit Fell on Increase in Provisions for Bad Loans
By Jeffrey T. Lewis
SÃO PAULO-- Banco Bradesco SA's profit declined in the first quarter from a year earlier after the Brazilian lender almost doubled its provisions for bad loans.
The Brazilian lender reported net income of 4.28 billion Brazilian reais, equivalent to $859 million, from 7.01 billion reais a year earlier. Recurring net income, which leaves out one-time items, declined to BRL4.28 billion from BRL6.82 billion, the bank said Thursday.
Net interest income fell to BRL16.65 billion from BRL17.06 billion a year earlier. Bradesco set aside BRL9.52 billion in the quarter as provisions for loan losses, after provisioning BRL4.84 billion in the same quarter a year earlier.
Bradesco and some other Brazilian lenders are setting aside more money as provisions for bad loans because more borrowers are having trouble repaying them. Bradesco's delinquency ratio of clients with loans more than 90 days past due increased to 5.1% from 3.2% in the year-earlier period.
Write to Jeffrey T. Lewis at jeffrey.lewis@wsj.com
(END) Dow Jones Newswires
May 04, 2023 18:28 ET (22:28 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm